Back to Search
Start Over
Subcutaneous immunoglobulin for the treatment of deep morphoea in a child.
- Source :
-
Clinical and experimental dermatology [Clin Exp Dermatol] 2018 Apr; Vol. 43 (3), pp. 303-305. Date of Electronic Publication: 2017 Dec 27. - Publication Year :
- 2018
-
Abstract
- Morphoea, also known as localized scleroderma, is a disorder characterized by excessive collagen deposition leading to thickening of the dermis and/or subcutaneous tissues. Intravenous IgG therapy has induced improvement in some fibrotic conditions. The primary indication for subcutaneous IgG (SCIG) is in primary immunodeficiency disorders as replacement therapy; however, recently there has been considerable interest in SCIG as an immunomodulatory agent. We report an 11-year-old girl with deep morphoea who was successfully treated with SCIG.<br /> (© 2017 British Association of Dermatologists.)
Details
- Language :
- English
- ISSN :
- 1365-2230
- Volume :
- 43
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical and experimental dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 29280519
- Full Text :
- https://doi.org/10.1111/ced.13352